EXPRES2ION BIOTECHNOLOGIES ApS: Financial statements 2012
CVR: 32770487
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
EXPRES2ION BIOTECHNOLOGIES ApS (CVR 32770487) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 1,616,505 and a net result of DKK -1,779,867. Equity in the 2012 report amounted to DKK 1,026,171. The solvency ratio was 56.3%.
- Gross Profit
- DKK 1,616,505
- Profit/Loss
- DKK -1,779,867
- Equity
- DKK 1,026,171
- Total Assets
- DKK 1,823,779
Official annual report
Keep an eye on EXPRES2ION BIOTECHNOLOGIES ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout EXPRES2ION BIOTECHNOLOGIES ApS
EXPRES2ION BIOTECHNOLOGIES ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ApS KBURS 17 NR. 6965. The management consists of Bent Ulrich Frandsen. The board consists of Martin Roland Jensen (chair), Jakob Ole Knudsen, Karin Garre and Michel Jean Baijot. The company is owned by Expres2ion Biotech Holding AB. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -9,158,236 and a net result of DKK -21,948,253 compared with DKK -19,830,535 the year before. Equity in the 2025 report amounted to DKK 23,950,262.